New research in Nature explores a fascinating possibility

What if “magic mushrooms” could do more than just open your mind? What if they could also help you live longer and healthier?

That’s the question raised by a striking new study from researchers at Emory University and Baylor College of Medicine, published last week in npj Aging, a journal in the Nature family. The scientists discovered that psilocybin, the active compound in psychedelic mushrooms, may actually slow biological aging.

Specifically, they found that psilocin, the form psilocybin takes after your body metabolizes it, extended the lifespan of human cells in culture and also improved survival rates in older mice.

If these findings hold up in further research, they could completely change how we see psychedelics, not just as a therapy for the mind but as a potential ally in the fight against aging itself.

Let’s unpack what they found.

The Study That Got Everyone Talking

To see how psilocybin affects aging, the researchers started at the cellular level. They exposed human fetal lung fibroblasts, a type of cell that maintains lung structure, to psilocin in both low and high doses and then watched how long the cells kept dividing before entering senescence, the point where cells stop replicating and just grow old.

The results were remarkable

• Cells lived 29% longer with a low dose

• With a higher dose, lifespan jumped by 57%

• Cells showed less DNA damage and oxidative stress

• Activity of SIRT1, a gene linked to longevity, was higher

• Telomeres, the protective caps on chromosomes that erode over time, were better preserved

In other words, the cells didn’t just live longer, they aged better.

But the researchers didn’t stop there. They wanted to see what happened in living creatures.

So they gave monthly doses of psilocybin to 19-month-old female mice, about the equivalent of a 60-year-old human, for 10 months. By the end of the study

• 80% of psilocybin-treated mice were still alive

• In the control group, only 50% survived

That’s a big difference, and it begs the question: how is this even possible?

How Could This Work?

Psilocybin mainly works by activating the serotonin 5-HT2A receptor in the brain. But here’s the thing: those receptors aren’t just in your brain. They’re found all over your body in your skin, heart, immune cells, and more.

Previous research suggests that activating these receptors ramps up SIRT1 activity, which helps protect cells from age-related damage and oxidative stress. This pathway could explain why psilocybin seems to reduce cellular aging even in tissues outside the brain.

On top of that, the study authors suspect that epigenetic changes may play a role too. Psychedelics have been shown to change how genes are expressed, sometimes for weeks or months after a single dose, through mechanisms like DNA methylation and chromatin remodeling.

This could also explain why psilocybin has such long-lasting effects on mood, anxiety, and now perhaps aging.

Of course, we have to be cautious. What works in cells and mice doesn’t always translate to humans. Large-scale human trials will be needed before we can say if psilocybin really slows aging in people.

Still, this research opens up an exciting and unexpected possibility.

What’s the Catch?

Even if psilocybin really is a powerful anti-aging compound, there’s a huge roadblock: its legal status.

In the U.S., psilocybin is still a Schedule I drug, legally defined as having “no accepted medical use” and a high potential for abuse. Many researchers and clinicians argue this is outdated, but it makes funding and conducting large clinical trials difficult.

While the FDA has already given psilocybin “breakthrough therapy” status for treating depression, expanding its use to healthy aging would require a major cultural and scientific shift.

Should We Be Excited?

Here’s my take: yes, cautiously.

This study is not a miracle cure, but it’s a fascinating piece of the puzzle. Every discovery like this helps us understand psychedelics more fully, not just as tools for mental health but potentially as allies in promoting healthy longevity.

We’re still in the early stages, and much remains to be explored. But studies like this show how much we still have to learn about the ancient compounds hiding in nature, waiting for us to notice what they can do.

If you want to follow the latest on psychedelic science, check out more of our coverage from Psychedelic Science 2025, and don’t miss our interview with Sam Chapman, founder of the Center for Psychedelic Policy, for a closer look at where science meets policy.

Psychedelics have already challenged how we think about consciousness and mental health. Now they might even change how we think about aging.

That’s worth paying attention to.